Alaunos Therapeutics, Inc. Defined Benefit Plan, Plan Assets, Contributions by Employer
Alaunos Therapeutics, Inc. (TCRT) reported Defined Benefit Plan, Plan Assets, Contributions by Employer of $13.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
us-gaap:DefinedBenefitPlanContributionsByEmployer · last filed 2026-03-31
- Alaunos Therapeutics, Inc. defined benefit plan, plan assets, contributions by employer for fiscal 2025 was $13.00K.
- Alaunos Therapeutics, Inc. defined benefit plan, plan assets, contributions by employer for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Alaunos Therapeutics, Inc. defined benefit plan, plan assets, contributions by employer for fiscal 2023 was $200.00K, a 60.00% decline from fiscal 2022.
- Alaunos Therapeutics, Inc. defined benefit plan, plan assets, contributions by employer for fiscal 2022 was $500.00K, a 28.57% decline from fiscal 2021.
| Period end | Defined Benefit Plan, Plan Assets, Contributions by Employer 12 month | Defined Benefit Plan, Plan Assets, Contributions by Employer 12 month as first filed |
|---|---|---|
| 2025-12-31 | $13.00K 10-K · filed 2026-03-31 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 | |
| 2023-12-31 | $200.00K 10-K · filed 2025-03-31 | |
| 2022-12-31 | $500.00K 10-K · filed 2024-04-01 | |
| 2021-12-31 | $700.00K 10-K · filed 2023-03-07 | |
| 2020-12-31 | $500.00K 10-K · filed 2022-03-30 | $538.00K 10-K · filed 2021-03-01 |
| 2019-12-31 | $404.00K 10-K · filed 2021-03-01 | |
| 2018-12-31 | $329.00K 10-K · filed 2021-03-01 | |
| 2017-12-31 | $90.00K 10-K · filed 2020-03-02 | |
| 2016-12-31 | $75.00K 10-K · filed 2019-03-05 | |
| 2015-12-31 | $47.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $79.00K 10-K · filed 2017-02-16 | |
| 2013-12-31 | $139.00K 10-K · filed 2016-02-24 | |
| 2012-12-31 | $266.00K 10-K · filed 2015-02-26 | |
| 2011-12-31 | $38.00K 10-K · filed 2014-03-03 | |
| 2010-12-31 | $21.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |